XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash Flows from Operating Activities    
Net loss $ (1,588,582) $ (1,695,631)
Adjustments to reconcile net loss from operations:    
Depreciation and amortization 55,685 61,014
Amortization of deferred financing costs 103,632 50,930
Loss on extinguishment of debt 790,723
Interest on convertible notes 53,725
Stock-based compensation expense 290,805 432,645
Beneficial conversion of Bridge notes 636,075
Gain on disposal of assets 13,815
Inventory write-offs 14,539 10,528
Bad debt expense 15,000 15,239
Changes in operating assets and liabilities:    
Accounts receivable 204,242 391,569
Inventories (111,770) (221,537)
Prepayments and other assets (1,178,239) (404,412)
Accounts payable and accrued expenses 1,162,059 (1,172,081)
Deposits (149,412) 651,336
Net Cash Provided By (Used In) Operating Activities 298,482 (1,866,585)
Cash Flows from Investing Activities    
Purchases of property and equipment (46,797)
Net Cash Used In Investing Activities (46,797)
Cash Flows from Financing Activities    
Proceeds from issuance of Revolving Facility 2,207,432
Proceeds from issuance of Term Loan 2,000,000
Proceeds from Revolving Facility advances 1,001,893
Repurchase of Common Stock (2,975,000)
Proceeds from issuance of Common Stock, net of offering costs 58,170,696
Debt financing costs (545,501)
Repayment of notes payable (5,755,845) (2,629,616)
Net Cash Provided by Financing Activities 49,439,851 2,034,208
Net Increase in Cash 49,738,333 120,826
Cash at Beginning of Period 184,469 448,703
Cash at End of Period 49,922,802 569,529
Supplemental Cash Flow Information:    
Interest Paid 317,443 298,634
Supplemental disclosure of non-cash investing and financing activities:    
Debt financing costs booked in equity $ 676,822